Targacept Drops as Depression Drug Misses Goal - Dec. 20, 2011

Having trouble viewing this email? View in Browser.

Tuesday, December 20, 2011  |   |   |   |  Pharm-Olam International Acquires StatWorks, Inc. With Pharm-Olam's acquisition of StatWorks we have expanded our team Data Management and Biostatistics experts for functional outsourcing and full service clinical trials. Our comprehensive biometric services include: • Integration of randomization into EDC systems, eliminating IVRS costs, with added benefit of full inventory control over supplies • Adaptive, Sequential, and Bayesian design methods • CDISC, SDTM and ADaM datasets • SAS programming, eCRF design, and medical coding in MedDRA/WHO Drug • Streamlining and reconciling across SAE, CTMS, and study DB • Health Outcomes Research and Patient Reported Outcomes • Protocol development, sample size, and randomization Contact us for your resource planning at www.pharm-olam.com, info@pharm-olam.com, USA 1-713-559-7900, UK 44-0-1344-891121 •  Targacept, Inc. (TRGT) Drops as Depression Drug Misses Goal More... •  Genzyme Corporation (GENZ) Reports Failing Results for TENERE Study of Oral Teriflunomide in Relapsing Multiple Sclerosis More... •  Salix Pharmaceuticals, Ltd. (SLXP) and Progenics Pharmaceuticals, Inc. (PGNX) Announce Positive Highly Statistically Significant Results of Oral Methylnaltrexone for Phase 3 Trial in Chronic, Non-Cancer Pain Subjects with Opioid-Induced Constipation More... •  Orexo AB: Positive Study Results for OX27 More... •  Dynavax Technologies Corporation (DVAX) Initiates Proof of Mechanism Trial in Lupus Patients More... More Phase III News More Phase II News More Phase I News More Pre-Clinical News More Post-Approval News •  FDA Further Restricts Use of Sanofi (France) (SAN.PA)'s Multaq More... More Discontinuations News More Recalls and Warning News •  Pfizer Inc. (PFE) Announces FDA Acceptance for Review of New Drug Application for Tofacitinib for Adult Patients With Moderately to Severely Active Rheumatoid Arthritis More... •  Zogenix, Inc. Completes Zohydro(TM) Pre-NDA Meetings With FDA More... •  Oncothyreon Files Investigational New Drug Application for ONT-10 More... More BLA/NDA/ANDA News More IND News More MAA News Quantifying the Value of Pipeline Pilot, the Accelrys Scientific Enterprise Platform This white paper outlines the methodology, sources of value, and quantifiable results from bringing products to market faster, avoiding unproductive experiments, saving developer time, and more. Request Now! •  Babies Remember Even as They Seem to Forget, Johns Hopkins University Study More... •  Molecular Markers Can Predict Spread of Cancer, Guide Treatment, University of Chicago Study More... •  Endometriosis Tied to Higher Risk of Crohn's, Colitis, Statens Serum Institut (SSI) Study More... •  Maggots Speed Up Cleaning of Stubborn Wounds, Centre Hospitalier Universitaire de Caen Study More... •  Mayo Clinic Release: Obesity Linked to Higher Five-Year Death Rate After Esophageal Cancer Surgery More... More General Clinical Research News SafeBridge Consultants, Inc. announces two Potent Compound Safety Training offerings (may be taken separately or consecutively) The SafeBridge original Potent Compound Safety "Boot Camp"® (Boot Camp I) is a comprehensive two-day course in pharmaceutical potent compound safety focused on training EH&S and related professionals in critical technical concepts and proactive safety programs in pharmaceutical industrial hygiene, occupational and environmental toxicology, analytical chemistry, and risk communication. The SafeBridge Advanced Concepts to Support Drug Development of Potent Compounds from R&D through Manufacturing (Boot Camp II) is a one-day advanced course focused on case studies and problem-solving to address potent compound safety issues in discovery, development, contract manufacturing and commercialization. COURSE SEATING IS LIMITED AND USUALLY SELLS OUT! San Diego, CA Boot Camp I May 15-16, 2012 Boot Camp II May 17, 2012 Contact: Susan Custer: susan.custer@safebridge.com, or 650-961-4820 x 231 or www.safebridge.com Optimizing Clinical Trials Through IT • Examine the trends shaping clinical trials. • Learn how social media are being used in patient recruitment. • Analyse the potential of electronic health record data in clinical development. Click Here for More Information. • BioForest (Woodinville, Washington) Bio-Rad Laboratories, Inc. Clinical Diagnostics Group RA/QA/QC Supervisor II Supervise and coordinate quality control activities for the BioPlex 2200 QC team in the Woodinville facility including raw materials QC, coupled antigens or antibodies to magnetic particles, conjugated antibodies with fluorescent tags, and critical component manufacturing. • Biotech Bay (South San Francisco, CA) Crescendo Bioscience Senior Clinical Research Associate Will monitor progress and activities of clinical studies and sites to assure adherence to Good Clinical Practices (GCPs), SOPs, and study protocols. The CRA will be responsible for multiple projects and must work both independently and in a team environment. • BioCapital (Rockville, Maryland) Otsuka America Pharmaceutical, Inc. Manager Clinical Development TB Will provide leadership and management for the microbiology procedures for the TB program and ensure quality of the endpoint assessment at global trial sites. S/he will ensure cross-study consistency in protocol design, data analysis, and reporting. • Genetown (Cambridge, Massachusetts) Cubist Pharmaceuticals, Inc. In House Clinical Research Associate Managing clinical study documentation (e.g. documentation for study start-up and IRB submission) and Trial Master File component. Knowledge of the processes involved in clinical studies following Good Clinical Practice (GCP) and the Code of Federal Regulations is required. • Biotech Beach (Irvine, California) Allergan Inc. Clinical Study Manager Will ensure that clinical strategies are translated into operational plans and executed in line with clinical development plans. In particular they will align operational execution activities with agreed upon project priorities, timings and quality specifications and adhere to all relevant regulations including GCP, ICH and PhRMA guidelines, Regulatory requirements, and Allergan's SOPs and policies. • Get Noticed! Add your resume to the BioSpace Career Center! • See more than 5,000 job postings in the BioSpace Career Center! BioSpace Life Science Career Fairs are the biotech industry's premier career events. Featuring well-respected employers from around the nation, our job fairs attract top candidates in the biotech, pharmaceutical, life science and medical device industries. With such a great number of recruiters and hiring managers from top biotech companies attending our career fairs, there are an abundance of opportunities available for job seekers. Many different disciplines within the industry are represented bringing a diversity of candidates to our job fairs. Companies seeking pharmaceutical sales representatives and marketing jobs regularly attend our job fairs. Engineering and technical jobs can be found, as well as regulatory jobs and positions in QA/QC. Individuals desiring a science job or a research job will find many opportunities at our job fairs. In addition, hiring managers seeking candidates for clinical research jobs also attend our events. More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services •  Nuvilex Associate Expands Ownership of Patents to Include Production of Therapeutic Antibodies More... •  Marshall Edwards, Inc. (MSHL) Awarded Key Patent for Compositions of Lead Oncology Drug Candidates More... More Patent News Hot Company Accelovance 2275 Research Boulevard, Suite 700 Rockville, Maryland 20850 U.S.A. Phone: 240-238-4900 Fax: 240-238-4901 Accelovance, Inc., based in Rockville, MD, is a clinical services company specializing in high patient throughput from recruitment through study completion. Accelovance has developed a model to increase the reliability and productivity on Phase I (outpatient) and Phase II-IV trials. Accelovance enhances this offering with flexible CRO services to meet a Sponsor's specific trial needs. More Company Profiles Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship ClinicaSpace 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 ClinicaSpace 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the ClinicaSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong ClinicaSpace.com - Clinical Trials. Clinical Research. Community. • ClinicaSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2011 ClinicaSpace http://www.clinicaspace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.